Opella Healthcare, Sanofi’s OTC division, has announced a dual partnership agreement with Alliance Healthcare and Phoenix Healthcare Distribution to supply OTC products to pharmacies in the UK.

The partnership, which was announced last week and is effective as of February 1, will offer “increased efficiency… improved service levels and stock availability” of Sanofi’s consumer healthcare range, the company said.

Opella, which trades as Sanofi Consumer Healthcare, is expected to demerge from Sanofi in the near future, with a divestment set to take place in the first quarter of the 2024 financial year at the earliest.Nick Linton, Sanofi Consumer Healthcare’s head of UK country operations, commented: “At Sanofi Consumer Healthcare we are committed to supporting the self care agenda in the UK.

“Making healthcare as simple as it should be to bring health and wellbeing to all is a key priority for us in 2024 and beyond. Our new wholesale model reflects our deep commitment to working as efficiently as possible in close partnership with pharmacists to shape a healthier future.”